Solara Active Pharma Sciences Ltd
Solara Active Pharma Sciences Ltd, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of active pharmaceutical ingredients (APIs) and intermediates. Founded in 2017, the company has quickly established itself as a key provider of high-quality products, catering to both domestic and international markets.
With a focus on innovation and sustainability, Solara offers a diverse range of APIs, particularly in the therapeutic areas of anti-infectives, cardiovascular, and central nervous system medications. The company’s commitment to quality and regulatory compliance has earned it a strong market position, with notable achievements in securing approvals from major global regulatory bodies. Solara's strategic operational regions extend across Asia, Europe, and the Americas, reinforcing its status as a trusted partner in the pharmaceutical supply chain.
-11 vs industry average
Solara Active Pharma Sciences Ltd’s score of 27 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Solara Active Pharma Sciences Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Solara Active Pharma Sciences Ltd's reported carbon emissions
In 2025, Solara Active Pharma Sciences Ltd reported total emissions of approximately 41,178,000 kg CO2e, comprising 12,118,000 kg CO2e from Scope 1 and 28,660,000 kg CO2e from Scope 2 emissions. The company has not disclosed any Scope 3 emissions data. Solara is committed to achieving net-zero emissions, as indicated by their near-term target status of "Committed." This commitment aligns with their operations in the Pharmaceuticals, Biotechnology, and Life Sciences sector, based in India. Over the past few years, emissions have fluctuated, with 2024 emissions recorded at approximately 77,112,000 kg CO2e (33,489,000 kg CO2e from Scope 1 and 43,622,000 kg CO2e from Scope 2) and 2023 emissions at approximately 54,430,000 kg CO2e (11,168,000 kg CO2e from Scope 1 and 43,425,000 kg CO2e from Scope 2). The company has not set specific reduction targets but remains focused on its long-term climate commitments. As of now, there are no emissions data cascaded from a parent or related organization.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Solara Active Pharma Sciences Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Solara Active Pharma Sciences Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Solara Active Pharma Sciences Ltd
Frequently asked questions
Common questions about Solara Active Pharma Sciences Ltd’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project